FDA Inspection 1295016 — AndersonBrecon Inc.
The FDA completed an inspection of AndersonBrecon Inc. on Aug 19, 2026 in Rockford, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 19, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rockford, IL (United States)